Maraviroc -: Anti-HIV agent viral entry inhibitor chemokine CCR5 antagonist

被引:8
|
作者
Ginesta, JB [1 ]
Castañer, J [1 ]
Bozzo, J [1 ]
Bayés, M [1 ]
机构
[1] Prous Sci, Barcelona 08080, Spain
关键词
4,4-difIuoro-N-[3-[(1R,3exo,5S)-3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]oct-8-yl]-1(S)-phenylpropy])cyclohexanecarboxamide;
D O I
10.1358/dof.2005.030.05.902712
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Despite the availability of several approved drugs for the treatment of human immunodeficiency virus (HIV) infection, the limited effectiveness of current antiretroviral regimens, mainly due to the emergence of resistance, makes the development of new agents necessary. Several novel compounds are being added to existing classes, but newer classes of antiretroviral drugs, such as HIV entry inhibitors, are also under development. Maraviroc is a novel small molecule that specifically antagonizes the chemokine CCR5 receptor required for efficient HIV entry. It displays potent and broad-spectrum anti-HIV activity and excellent pharmacokinetic and safety profiles. All these features and the promising results obtained in early clinical trials make this agent a good candidate for inclusion in combination therapies for HIV treatment. Maraviroc is the most clinically advanced CCR5 antagonist and has just entered phase III clinical trials.
引用
收藏
页码:469 / 477
页数:9
相关论文
共 50 条
  • [41] Molecular binding mode of PF-232798, a clinical anti-HIV candidate, at chemokine receptor CCR5
    Zhu, Ya
    Zhao, Yan-long
    Li, Jian
    Liu, Hong
    Zhao, Qiang
    Wu, Bei-li
    Yang, Zhen-lin
    ACTA PHARMACOLOGICA SINICA, 2019, 40 (04) : 563 - 568
  • [42] Molecular binding mode of PF-232798, a clinical anti-HIV candidate, at chemokine receptor CCR5
    Ya Zhu
    Yan-long Zhao
    Jian Li
    Hong Liu
    Qiang Zhao
    Bei-li Wu
    Zhen-lin Yang
    Acta Pharmacologica Sinica, 2019, 40 : 563 - 568
  • [43] The CC Chemokine Receptor 5 (CCR5) antagonist Maraviroc inhibits drug-choice in Sprague Dawley rats
    Mason, Briana
    Seaman, Robert, Jr.
    Collins, Gregory
    FASEB JOURNAL, 2021, 35
  • [44] CCR5: From Natural Resistance to a New Anti-HIV Strategy
    Lopalco, Lucia
    VIRUSES-BASEL, 2010, 2 (02): : 574 - 600
  • [45] Binding of fusion protein FLSC IgG1 to CCR5 is enhanced by CCR5 antagonist Maraviroc
    Latinovic, Olga
    Szmacinski, Henryk
    Schneider, Kate
    Lakowicz, Joseph
    Heredia, Alonso
    Redfield, Robert
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 67 : 82 - 82
  • [46] Binding of fusion protein FLSC IgG1 to CCR5 is enhanced by CCR5 antagonist Maraviroc
    Latinovic, Olga
    Schneider, Kate
    Szmacinski, Henryk
    Lakowicz, Joseph R.
    Heredia, Alonso
    Redfield, Robert R.
    ANTIVIRAL RESEARCH, 2014, 112 : 80 - 90
  • [47] Analysis and dissociation of anti-HIV effects of shRNA to CCR5 and the fusion inhibitor C46
    Ledger, Scott
    Howe, Annett
    Turville, Stuart
    Aggarwal, Anupriya
    Savkovic, Borislav
    Ong, Andrew
    Wolstein, Orit
    Boyd, Maureen
    Millington, Michelle
    Gorry, Paul R.
    Murray, John M.
    Symonds, Geoff
    JOURNAL OF GENE MEDICINE, 2018, 20 (2-3):
  • [48] Natural proteolytic processing of hemofiltrate CC chemokine 1 generates a potent CC chemokine receptor (CCR)1 and CCR5 agonist with anti-HIV properties
    Detheux, M
    Ständker, L
    Vakili, J
    Münch, J
    Forssmann, U
    Adermann, K
    Pöhlmann, S
    Vassart, G
    Kirchhoff, F
    Parmentier, M
    Forssmann, WG
    JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (10): : 1501 - 1508
  • [49] Downregulation of Leukocyte Migration After Treatment With CCR5 Antagonist Maraviroc
    Rossi, Raffaella
    Lichtner, Miriam
    Sauzullo, Ilaria
    Mengoni, Fabio
    Marocco, Raffaella
    Massetti, Anna Paola
    Mastroianni, Claudio Maria
    Vullo, Vincenzo
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2010, 54 (05) : E13 - E14
  • [50] Investigating HIV-1 Resistance to CCR5 Antagonist Maraviroc for the Design of New Prevention Strategies
    Flynn, Jacqueline K.
    Roche, Michael
    Paukovics, Geza
    Salimi, Hamid
    Duncan, Renee C.
    Moore, Miranda S.
    Ellet, Anne
    Gray, Lachlan R.
    Jubb, Becky
    Westby, Mike
    Purcell, Damian F. J.
    Lewin, Sharon R.
    Lee, Benhur
    Payne, Richard J.
    Churchill, Melissa J.
    Gorry, Paul R.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2014, 30 : A212 - A212